Synthesis and Antitumor Activity of 2,4,6-Trisubstituted Novel Quinazoline Derivatives Containing Trifluoromethyl

被引:0
|
作者
Wang Zhengjie [1 ,2 ]
Dai Honglin [1 ,2 ]
Si Xiaojie [1 ,2 ]
Gao Chao [1 ,2 ]
Liu Limin [1 ,2 ]
Zhang Luye [1 ,2 ]
Zhang Yang [1 ,2 ]
Song Yadan [1 ,2 ]
Zhao Peirong [1 ,2 ,3 ]
Zheng Jiaxin [1 ,2 ]
Ke Yu [1 ,2 ]
Liu Hongmin [1 ,2 ,3 ,4 ]
Zhang Qiurong [1 ,2 ,4 ]
机构
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Peoples R China
[3] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Peoples R China
[4] Zhengzhou Univ, Minist Educ China, Key Lab Adv Drug Preparat Technol, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
trifluoromethyl; quinazoline; synthesis; antitumor activity; INHIBITORS; DESIGN; SAR;
D O I
10.6023/cjoc202107026
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
In order to find efficient and low toxicity antitumor drugs, a series of novel 2,4,6-trisubstituted quinazoline derivatives containing trifluoromethyl were synthesized and evaluated for their antitumor activities against human cancer cell lines (PC-3, MCF-7, Eca-109, MGC-803, HGC-27, A549, H1975) by using methyl thiazolyl tetrazolium (MTT) assay. Most of compounds exerted moderate to excellent antitumor activity against seven human cancer cells. Among them, N-(3-bromophenyl)-6-methoxy-2-04-(trifluoromethyl)benzyl)thio)quinazolin-4-amine (161) showed the best antitumor activity against PC-3 cancer cell line, with the IC50 values of (2.22 +/- 0.15) mu mol/L, which was better than the positive control of gefitinib. At the same time, and compound 161 could dose-dependently and time-dependently induce PC-3 cells apoptosis.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 27 条
  • [1] Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities
    Akhtar, Jawaid
    Khan, Ahsan Ahmed
    Ali, Zulphikar
    Haider, Rafi
    Yar, M. Shahar
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 143 - 189
  • [2] Novel heterocyclic-fused pyrimidine derivatives: Synthesis, molecular modeling and pharmacological screening
    Arafa, Reem K.
    Nour, Mai S.
    El-Sayed, Nehad A.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 69 : 498 - 507
  • [3] Synthesis and anticonvulsant evaluation of some new 2,3,8-trisubstituted-4(3H)-quinazoline derivatives
    El-Azab, Adel S.
    ElTahir, Kamal E. H.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 327 - 333
  • [4] Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
    Elmetwally, Souad A.
    Saied, Khaled F.
    Eissd, Ibrahim H.
    Elkaeed, Eslam B.
    [J]. BIOORGANIC CHEMISTRY, 2019, 88
  • [5] Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives
    Fouad, Mahasen M.
    El-Bendary, Eman R.
    Suddek, Ghada M.
    Shehata, Ihsan A.
    El-Kerdawy, Mohamed M.
    [J]. BIOORGANIC CHEMISTRY, 2018, 81 : 587 - 598
  • [6] Design, facile synthesis, and evaluation of novel spiro- and pyrazolo [1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies
    Galvez, Jaime
    Polo, Stivens
    Insuasty, Braulio
    Gutierrez, Margarita
    Caceres, Daniela
    Alzate-Morales, Jans H.
    De-la-Torre, Pedro
    Quiroga, Jairo
    [J]. COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2018, 74 : 218 - 229
  • [7] Synthesis and evaluation of 2,9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitors
    Hei, Yuan-Yuan
    Shen, Ying
    Wang, Jin
    Zhang, Hao
    Zhao, Hong-Yi
    Xin, Minhang
    Cao, Yong-Xiao
    Li, Yan
    Zhang, San-Qi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 2173 - 2185
  • [8] Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives as Anti-inflammatory Agents against Lipopolysaccharide-induced Acute Lung Injury in Rats
    Hu, Jie
    Zhang, Yali
    Dong, Lili
    Wang, Zhe
    Chen, Lingfeng
    Liang, Dandan
    Shi, Dengjian
    Shan, Xiaoou
    Liang, Guang
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) : 672 - 684
  • [9] Fluorine in medicinal chemistry: A review of anti-cancer agents
    Isanbor, C
    O'Hagan, D
    [J]. JOURNAL OF FLUORINE CHEMISTRY, 2006, 127 (03) : 303 - 319
  • [10] Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents
    Ji, Qinggang
    Yang, Dan
    Wang, Xin
    Chen, Chunyan
    Deng, Qiao
    Ge, Zhiqiang
    Yuan, Lvjiang
    Yang, Xiaolan
    Liao, Fei
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (13) : 3405 - 3413